nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—prostate cancer	0.423	0.732	CbGaD
Amiloride—SLC22A1—prostate cancer	0.155	0.268	CbGaD
Amiloride—SLC22A2—Estradiol—prostate cancer	0.0191	0.535	CbGbCtD
Amiloride—SLC22A1—Estradiol—prostate cancer	0.0166	0.465	CbGbCtD
Amiloride—SCNN1G—prostate gland—prostate cancer	0.00348	0.0372	CbGeAlD
Amiloride—SCNN1D—prostate gland—prostate cancer	0.00348	0.0372	CbGeAlD
Amiloride—ASIC1—prostate gland—prostate cancer	0.00341	0.0365	CbGeAlD
Amiloride—AOC1—prostate gland—prostate cancer	0.00341	0.0365	CbGeAlD
Amiloride—SLC9A1—prostate gland—prostate cancer	0.00327	0.035	CbGeAlD
Amiloride—PLAU—prostate gland—prostate cancer	0.0031	0.0332	CbGeAlD
Amiloride—SCNN1G—seminal vesicle—prostate cancer	0.00294	0.0315	CbGeAlD
Amiloride—SCNN1B—prostate gland—prostate cancer	0.00294	0.0314	CbGeAlD
Amiloride—SCNN1A—prostate gland—prostate cancer	0.00272	0.029	CbGeAlD
Amiloride—PLAU—seminal vesicle—prostate cancer	0.00262	0.028	CbGeAlD
Amiloride—SCNN1D—epithelium—prostate cancer	0.00256	0.0273	CbGeAlD
Amiloride—SLC9A1—epithelium—prostate cancer	0.0024	0.0257	CbGeAlD
Amiloride—SCNN1G—renal system—prostate cancer	0.00237	0.0254	CbGeAlD
Amiloride—SCNN1G—urethra—prostate cancer	0.00233	0.0249	CbGeAlD
Amiloride—AOC1—renal system—prostate cancer	0.00233	0.0249	CbGeAlD
Amiloride—AOC1—urethra—prostate cancer	0.00229	0.0244	CbGeAlD
Amiloride—PLAU—epithelium—prostate cancer	0.00228	0.0244	CbGeAlD
Amiloride—SLC9A1—renal system—prostate cancer	0.00223	0.0238	CbGeAlD
Amiloride—SCNN1B—epithelium—prostate cancer	0.00216	0.0231	CbGeAlD
Amiloride—PLAU—renal system—prostate cancer	0.00211	0.0226	CbGeAlD
Amiloride—PLAU—urethra—prostate cancer	0.00208	0.0222	CbGeAlD
Amiloride—SCNN1B—renal system—prostate cancer	0.002	0.0214	CbGeAlD
Amiloride—SCNN1A—epithelium—prostate cancer	0.002	0.0213	CbGeAlD
Amiloride—SCNN1B—urethra—prostate cancer	0.00197	0.021	CbGeAlD
Amiloride—SCNN1A—renal system—prostate cancer	0.00185	0.0198	CbGeAlD
Amiloride—SCNN1A—urethra—prostate cancer	0.00182	0.0194	CbGeAlD
Amiloride—AOC1—bone marrow—prostate cancer	0.00176	0.0188	CbGeAlD
Amiloride—SLC9A1—bone marrow—prostate cancer	0.00169	0.018	CbGeAlD
Amiloride—PLAU—bone marrow—prostate cancer	0.0016	0.0171	CbGeAlD
Amiloride—SCNN1D—testis—prostate cancer	0.00153	0.0164	CbGeAlD
Amiloride—ASIC1—testis—prostate cancer	0.0015	0.0161	CbGeAlD
Amiloride—AOC1—testis—prostate cancer	0.0015	0.0161	CbGeAlD
Amiloride—SLC9A1—testis—prostate cancer	0.00144	0.0154	CbGeAlD
Amiloride—PLAU—testis—prostate cancer	0.00137	0.0146	CbGeAlD
Amiloride—SCNN1B—testis—prostate cancer	0.00129	0.0138	CbGeAlD
Amiloride—SCNN1A—testis—prostate cancer	0.0012	0.0128	CbGeAlD
Amiloride—SCNN1D—lymph node—prostate cancer	0.00111	0.0119	CbGeAlD
Amiloride—AOC1—lymph node—prostate cancer	0.00109	0.0117	CbGeAlD
Amiloride—ASIC1—lymph node—prostate cancer	0.00109	0.0117	CbGeAlD
Amiloride—SLC22A4—prostate gland—prostate cancer	0.00109	0.0116	CbGeAlD
Amiloride—SLC9A1—lymph node—prostate cancer	0.00104	0.0112	CbGeAlD
Amiloride—SLC22A2—renal system—prostate cancer	0.000999	0.0107	CbGeAlD
Amiloride—PLAU—lymph node—prostate cancer	0.00099	0.0106	CbGeAlD
Amiloride—SCNN1B—lymph node—prostate cancer	0.000938	0.01	CbGeAlD
Amiloride—SLC22A4—seminal vesicle—prostate cancer	0.00092	0.00984	CbGeAlD
Amiloride—SCNN1A—lymph node—prostate cancer	0.000867	0.00927	CbGeAlD
Amiloride—PLAU—Betamethasone—Prednisone—prostate cancer	0.000787	0.5	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Prednisone—prostate cancer	0.000787	0.5	CbGdCrCtD
Amiloride—SLC22A4—renal system—prostate cancer	0.000741	0.00793	CbGeAlD
Amiloride—SLC22A1—renal system—prostate cancer	0.000706	0.00755	CbGeAlD
Amiloride—SLC22A4—bone marrow—prostate cancer	0.00056	0.006	CbGeAlD
Amiloride—SLC22A4—lymph node—prostate cancer	0.000347	0.00371	CbGeAlD
Amiloride—Orthostatic hypotension—Epirubicin—prostate cancer	0.000102	0.000657	CcSEcCtD
Amiloride—Fatigue—Mitoxantrone—prostate cancer	0.000101	0.000653	CcSEcCtD
Amiloride—Vomiting—Goserelin—prostate cancer	0.000101	0.000652	CcSEcCtD
Amiloride—Alopecia—Docetaxel—prostate cancer	0.000101	0.000652	CcSEcCtD
Amiloride—Pain—Mitoxantrone—prostate cancer	0.0001	0.000648	CcSEcCtD
Amiloride—Constipation—Mitoxantrone—prostate cancer	0.0001	0.000648	CcSEcCtD
Amiloride—Bradycardia—Prednisone—prostate cancer	0.0001	0.000647	CcSEcCtD
Amiloride—Rash—Goserelin—prostate cancer	0.0001	0.000647	CcSEcCtD
Amiloride—Dermatitis—Goserelin—prostate cancer	0.0001	0.000646	CcSEcCtD
Amiloride—Vomiting—Conjugated Estrogens—prostate cancer	0.0001	0.000646	CcSEcCtD
Amiloride—Abdominal pain—Estradiol—prostate cancer	9.97e-05	0.000643	CcSEcCtD
Amiloride—Headache—Goserelin—prostate cancer	9.96e-05	0.000643	CcSEcCtD
Amiloride—Rash—Conjugated Estrogens—prostate cancer	9.93e-05	0.000641	CcSEcCtD
Amiloride—Dermatitis—Conjugated Estrogens—prostate cancer	9.92e-05	0.00064	CcSEcCtD
Amiloride—Haemoglobin—Prednisone—prostate cancer	9.91e-05	0.000639	CcSEcCtD
Amiloride—Headache—Conjugated Estrogens—prostate cancer	9.87e-05	0.000637	CcSEcCtD
Amiloride—Haemorrhage—Prednisone—prostate cancer	9.86e-05	0.000636	CcSEcCtD
Amiloride—Confusional state—Etoposide—prostate cancer	9.85e-05	0.000636	CcSEcCtD
Amiloride—Muscular weakness—Epirubicin—prostate cancer	9.83e-05	0.000634	CcSEcCtD
Amiloride—Alopecia—Capecitabine—prostate cancer	9.78e-05	0.000631	CcSEcCtD
Amiloride—Abdominal distension—Epirubicin—prostate cancer	9.7e-05	0.000626	CcSEcCtD
Amiloride—Feeling abnormal—Mitoxantrone—prostate cancer	9.68e-05	0.000624	CcSEcCtD
Amiloride—Back pain—Docetaxel—prostate cancer	9.63e-05	0.000621	CcSEcCtD
Amiloride—Gastrointestinal pain—Mitoxantrone—prostate cancer	9.61e-05	0.00062	CcSEcCtD
Amiloride—Muscle spasms—Docetaxel—prostate cancer	9.57e-05	0.000617	CcSEcCtD
Amiloride—Flatulence—Capecitabine—prostate cancer	9.49e-05	0.000612	CcSEcCtD
Amiloride—Nausea—Goserelin—prostate cancer	9.45e-05	0.000609	CcSEcCtD
Amiloride—Orthostatic hypotension—Doxorubicin—prostate cancer	9.42e-05	0.000608	CcSEcCtD
Amiloride—Angina pectoris—Epirubicin—prostate cancer	9.38e-05	0.000605	CcSEcCtD
Amiloride—Nausea—Conjugated Estrogens—prostate cancer	9.36e-05	0.000604	CcSEcCtD
Amiloride—Back pain—Capecitabine—prostate cancer	9.32e-05	0.000601	CcSEcCtD
Amiloride—Anorexia—Etoposide—prostate cancer	9.32e-05	0.000601	CcSEcCtD
Amiloride—Abdominal pain—Mitoxantrone—prostate cancer	9.29e-05	0.000599	CcSEcCtD
Amiloride—Muscle spasms—Capecitabine—prostate cancer	9.26e-05	0.000597	CcSEcCtD
Amiloride—Muscular weakness—Doxorubicin—prostate cancer	9.1e-05	0.000587	CcSEcCtD
Amiloride—Asthenia—Estradiol—prostate cancer	9.05e-05	0.000584	CcSEcCtD
Amiloride—Tremor—Capecitabine—prostate cancer	9.03e-05	0.000582	CcSEcCtD
Amiloride—Neutropenia—Epirubicin—prostate cancer	9.01e-05	0.000581	CcSEcCtD
Amiloride—Dysuria—Epirubicin—prostate cancer	9.01e-05	0.000581	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—prostate cancer	8.97e-05	0.000579	CcSEcCtD
Amiloride—Pruritus—Estradiol—prostate cancer	8.92e-05	0.000575	CcSEcCtD
Amiloride—Pollakiuria—Epirubicin—prostate cancer	8.9e-05	0.000574	CcSEcCtD
Amiloride—Palpitations—Docetaxel—prostate cancer	8.79e-05	0.000567	CcSEcCtD
Amiloride—Paraesthesia—Etoposide—prostate cancer	8.78e-05	0.000566	CcSEcCtD
Amiloride—Dyspnoea—Etoposide—prostate cancer	8.71e-05	0.000562	CcSEcCtD
Amiloride—Alopecia—Prednisone—prostate cancer	8.71e-05	0.000562	CcSEcCtD
Amiloride—Somnolence—Etoposide—prostate cancer	8.69e-05	0.00056	CcSEcCtD
Amiloride—Cough—Docetaxel—prostate cancer	8.68e-05	0.00056	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—prostate cancer	8.68e-05	0.00056	CcSEcCtD
Amiloride—Vertigo—Capecitabine—prostate cancer	8.66e-05	0.000558	CcSEcCtD
Amiloride—Diarrhoea—Estradiol—prostate cancer	8.63e-05	0.000556	CcSEcCtD
Amiloride—Palpitations—Capecitabine—prostate cancer	8.51e-05	0.000549	CcSEcCtD
Amiloride—Decreased appetite—Etoposide—prostate cancer	8.5e-05	0.000548	CcSEcCtD
Amiloride—Arthralgia—Docetaxel—prostate cancer	8.47e-05	0.000546	CcSEcCtD
Amiloride—Chest pain—Docetaxel—prostate cancer	8.47e-05	0.000546	CcSEcCtD
Amiloride—Gastrointestinal disorder—Etoposide—prostate cancer	8.44e-05	0.000544	CcSEcCtD
Amiloride—Asthenia—Mitoxantrone—prostate cancer	8.43e-05	0.000544	CcSEcCtD
Amiloride—Fatigue—Etoposide—prostate cancer	8.43e-05	0.000543	CcSEcCtD
Amiloride—Cough—Capecitabine—prostate cancer	8.41e-05	0.000542	CcSEcCtD
Amiloride—Jaundice—Epirubicin—prostate cancer	8.37e-05	0.00054	CcSEcCtD
Amiloride—Pain—Etoposide—prostate cancer	8.36e-05	0.000539	CcSEcCtD
Amiloride—Constipation—Etoposide—prostate cancer	8.36e-05	0.000539	CcSEcCtD
Amiloride—Dizziness—Estradiol—prostate cancer	8.34e-05	0.000538	CcSEcCtD
Amiloride—Neutropenia—Doxorubicin—prostate cancer	8.33e-05	0.000538	CcSEcCtD
Amiloride—Dysuria—Doxorubicin—prostate cancer	8.33e-05	0.000538	CcSEcCtD
Amiloride—Pollakiuria—Doxorubicin—prostate cancer	8.23e-05	0.000531	CcSEcCtD
Amiloride—Chest pain—Capecitabine—prostate cancer	8.2e-05	0.000529	CcSEcCtD
Amiloride—Arthralgia—Capecitabine—prostate cancer	8.2e-05	0.000529	CcSEcCtD
Amiloride—Confusional state—Docetaxel—prostate cancer	8.19e-05	0.000528	CcSEcCtD
Amiloride—Feeling abnormal—Etoposide—prostate cancer	8.05e-05	0.000519	CcSEcCtD
Amiloride—Diarrhoea—Mitoxantrone—prostate cancer	8.04e-05	0.000519	CcSEcCtD
Amiloride—Vomiting—Estradiol—prostate cancer	8.02e-05	0.000517	CcSEcCtD
Amiloride—Gastrointestinal pain—Etoposide—prostate cancer	7.99e-05	0.000515	CcSEcCtD
Amiloride—Shock—Docetaxel—prostate cancer	7.99e-05	0.000515	CcSEcCtD
Amiloride—Rash—Estradiol—prostate cancer	7.95e-05	0.000513	CcSEcCtD
Amiloride—Dermatitis—Estradiol—prostate cancer	7.94e-05	0.000512	CcSEcCtD
Amiloride—Confusional state—Capecitabine—prostate cancer	7.93e-05	0.000511	CcSEcCtD
Amiloride—Headache—Estradiol—prostate cancer	7.9e-05	0.00051	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—prostate cancer	7.85e-05	0.000506	CcSEcCtD
Amiloride—Haemoglobin—Epirubicin—prostate cancer	7.75e-05	0.0005	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—prostate cancer	7.75e-05	0.0005	CcSEcCtD
Amiloride—Anorexia—Docetaxel—prostate cancer	7.74e-05	0.000499	CcSEcCtD
Amiloride—Shock—Capecitabine—prostate cancer	7.74e-05	0.000499	CcSEcCtD
Amiloride—Abdominal pain—Etoposide—prostate cancer	7.73e-05	0.000498	CcSEcCtD
Amiloride—Vertigo—Prednisone—prostate cancer	7.71e-05	0.000497	CcSEcCtD
Amiloride—Haemorrhage—Epirubicin—prostate cancer	7.71e-05	0.000497	CcSEcCtD
Amiloride—Anorexia—Capecitabine—prostate cancer	7.5e-05	0.000483	CcSEcCtD
Amiloride—Nausea—Estradiol—prostate cancer	7.49e-05	0.000483	CcSEcCtD
Amiloride—Vomiting—Mitoxantrone—prostate cancer	7.47e-05	0.000482	CcSEcCtD
Amiloride—Visual impairment—Epirubicin—prostate cancer	7.43e-05	0.000479	CcSEcCtD
Amiloride—Rash—Mitoxantrone—prostate cancer	7.41e-05	0.000478	CcSEcCtD
Amiloride—Dermatitis—Mitoxantrone—prostate cancer	7.4e-05	0.000477	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.4e-05	0.000477	CcSEcCtD
Amiloride—Headache—Mitoxantrone—prostate cancer	7.36e-05	0.000475	CcSEcCtD
Amiloride—Insomnia—Docetaxel—prostate cancer	7.35e-05	0.000474	CcSEcCtD
Amiloride—Arthralgia—Prednisone—prostate cancer	7.31e-05	0.000471	CcSEcCtD
Amiloride—Paraesthesia—Docetaxel—prostate cancer	7.29e-05	0.00047	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—prostate cancer	7.26e-05	0.000468	CcSEcCtD
Amiloride—Dyspnoea—Docetaxel—prostate cancer	7.24e-05	0.000467	CcSEcCtD
Amiloride—Somnolence—Docetaxel—prostate cancer	7.22e-05	0.000466	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—prostate cancer	7.19e-05	0.000464	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—prostate cancer	7.17e-05	0.000463	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.16e-05	0.000462	CcSEcCtD
Amiloride—Dyspepsia—Docetaxel—prostate cancer	7.15e-05	0.000461	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—prostate cancer	7.13e-05	0.00046	CcSEcCtD
Amiloride—Insomnia—Capecitabine—prostate cancer	7.11e-05	0.000459	CcSEcCtD
Amiloride—Paraesthesia—Capecitabine—prostate cancer	7.06e-05	0.000455	CcSEcCtD
Amiloride—Decreased appetite—Docetaxel—prostate cancer	7.06e-05	0.000455	CcSEcCtD
Amiloride—Gastrointestinal disorder—Docetaxel—prostate cancer	7.01e-05	0.000452	CcSEcCtD
Amiloride—Asthenia—Etoposide—prostate cancer	7.01e-05	0.000452	CcSEcCtD
Amiloride—Dyspnoea—Capecitabine—prostate cancer	7.01e-05	0.000452	CcSEcCtD
Amiloride—Fatigue—Docetaxel—prostate cancer	7e-05	0.000452	CcSEcCtD
Amiloride—Nausea—Mitoxantrone—prostate cancer	6.98e-05	0.00045	CcSEcCtD
Amiloride—Pain—Docetaxel—prostate cancer	6.95e-05	0.000448	CcSEcCtD
Amiloride—Constipation—Docetaxel—prostate cancer	6.95e-05	0.000448	CcSEcCtD
Amiloride—Dyspepsia—Capecitabine—prostate cancer	6.92e-05	0.000446	CcSEcCtD
Amiloride—Pruritus—Etoposide—prostate cancer	6.91e-05	0.000446	CcSEcCtD
Amiloride—Shock—Prednisone—prostate cancer	6.89e-05	0.000444	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—prostate cancer	6.88e-05	0.000443	CcSEcCtD
Amiloride—Decreased appetite—Capecitabine—prostate cancer	6.84e-05	0.000441	CcSEcCtD
Amiloride—Alopecia—Epirubicin—prostate cancer	6.81e-05	0.000439	CcSEcCtD
Amiloride—Gastrointestinal disorder—Capecitabine—prostate cancer	6.79e-05	0.000438	CcSEcCtD
Amiloride—Fatigue—Capecitabine—prostate cancer	6.78e-05	0.000437	CcSEcCtD
Amiloride—Pain—Capecitabine—prostate cancer	6.72e-05	0.000434	CcSEcCtD
Amiloride—Constipation—Capecitabine—prostate cancer	6.72e-05	0.000434	CcSEcCtD
Amiloride—Feeling abnormal—Docetaxel—prostate cancer	6.69e-05	0.000432	CcSEcCtD
Amiloride—Diarrhoea—Etoposide—prostate cancer	6.69e-05	0.000431	CcSEcCtD
Amiloride—Anorexia—Prednisone—prostate cancer	6.68e-05	0.000431	CcSEcCtD
Amiloride—Tinnitus—Doxorubicin—prostate cancer	6.65e-05	0.000429	CcSEcCtD
Amiloride—Gastrointestinal pain—Docetaxel—prostate cancer	6.64e-05	0.000428	CcSEcCtD
Amiloride—Flatulence—Epirubicin—prostate cancer	6.61e-05	0.000427	CcSEcCtD
Amiloride—Tension—Epirubicin—prostate cancer	6.59e-05	0.000425	CcSEcCtD
Amiloride—Nervousness—Epirubicin—prostate cancer	6.52e-05	0.00042	CcSEcCtD
Amiloride—Back pain—Epirubicin—prostate cancer	6.49e-05	0.000419	CcSEcCtD
Amiloride—Feeling abnormal—Capecitabine—prostate cancer	6.48e-05	0.000418	CcSEcCtD
Amiloride—Dizziness—Etoposide—prostate cancer	6.46e-05	0.000417	CcSEcCtD
Amiloride—Muscle spasms—Epirubicin—prostate cancer	6.45e-05	0.000416	CcSEcCtD
Amiloride—Gastrointestinal pain—Capecitabine—prostate cancer	6.43e-05	0.000415	CcSEcCtD
Amiloride—Abdominal pain—Docetaxel—prostate cancer	6.42e-05	0.000414	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Prednisone—prostate cancer	6.38e-05	0.000412	CcSEcCtD
Amiloride—Insomnia—Prednisone—prostate cancer	6.33e-05	0.000409	CcSEcCtD
Amiloride—Alopecia—Doxorubicin—prostate cancer	6.3e-05	0.000407	CcSEcCtD
Amiloride—Paraesthesia—Prednisone—prostate cancer	6.29e-05	0.000406	CcSEcCtD
Amiloride—Abdominal pain—Capecitabine—prostate cancer	6.22e-05	0.000401	CcSEcCtD
Amiloride—Vomiting—Etoposide—prostate cancer	6.21e-05	0.000401	CcSEcCtD
Amiloride—Dyspepsia—Prednisone—prostate cancer	6.17e-05	0.000398	CcSEcCtD
Amiloride—Rash—Etoposide—prostate cancer	6.16e-05	0.000397	CcSEcCtD
Amiloride—Dermatitis—Etoposide—prostate cancer	6.16e-05	0.000397	CcSEcCtD
Amiloride—Headache—Etoposide—prostate cancer	6.12e-05	0.000395	CcSEcCtD
Amiloride—Flatulence—Doxorubicin—prostate cancer	6.12e-05	0.000395	CcSEcCtD
Amiloride—Tension—Doxorubicin—prostate cancer	6.09e-05	0.000393	CcSEcCtD
Amiloride—Decreased appetite—Prednisone—prostate cancer	6.09e-05	0.000393	CcSEcCtD
Amiloride—Fatigue—Prednisone—prostate cancer	6.04e-05	0.00039	CcSEcCtD
Amiloride—Nervousness—Doxorubicin—prostate cancer	6.03e-05	0.000389	CcSEcCtD
Amiloride—Vertigo—Epirubicin—prostate cancer	6.03e-05	0.000389	CcSEcCtD
Amiloride—Back pain—Doxorubicin—prostate cancer	6.01e-05	0.000387	CcSEcCtD
Amiloride—Constipation—Prednisone—prostate cancer	5.99e-05	0.000386	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—prostate cancer	5.97e-05	0.000385	CcSEcCtD
Amiloride—Palpitations—Epirubicin—prostate cancer	5.93e-05	0.000383	CcSEcCtD
Amiloride—Cough—Epirubicin—prostate cancer	5.86e-05	0.000378	CcSEcCtD
Amiloride—Asthenia—Docetaxel—prostate cancer	5.83e-05	0.000376	CcSEcCtD
Amiloride—Nausea—Etoposide—prostate cancer	5.8e-05	0.000374	CcSEcCtD
Amiloride—Feeling abnormal—Prednisone—prostate cancer	5.77e-05	0.000372	CcSEcCtD
Amiloride—Pruritus—Docetaxel—prostate cancer	5.75e-05	0.000371	CcSEcCtD
Amiloride—Gastrointestinal pain—Prednisone—prostate cancer	5.73e-05	0.000369	CcSEcCtD
Amiloride—Chest pain—Epirubicin—prostate cancer	5.71e-05	0.000369	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—prostate cancer	5.71e-05	0.000369	CcSEcCtD
Amiloride—Asthenia—Capecitabine—prostate cancer	5.64e-05	0.000364	CcSEcCtD
Amiloride—Vertigo—Doxorubicin—prostate cancer	5.58e-05	0.00036	CcSEcCtD
Amiloride—Pruritus—Capecitabine—prostate cancer	5.56e-05	0.000359	CcSEcCtD
Amiloride—Diarrhoea—Docetaxel—prostate cancer	5.56e-05	0.000358	CcSEcCtD
Amiloride—Abdominal pain—Prednisone—prostate cancer	5.54e-05	0.000357	CcSEcCtD
Amiloride—Confusional state—Epirubicin—prostate cancer	5.52e-05	0.000356	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—prostate cancer	5.49e-05	0.000354	CcSEcCtD
Amiloride—Cough—Doxorubicin—prostate cancer	5.42e-05	0.00035	CcSEcCtD
Amiloride—Shock—Epirubicin—prostate cancer	5.39e-05	0.000348	CcSEcCtD
Amiloride—Diarrhoea—Capecitabine—prostate cancer	5.38e-05	0.000347	CcSEcCtD
Amiloride—Dizziness—Docetaxel—prostate cancer	5.37e-05	0.000346	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—prostate cancer	5.29e-05	0.000341	CcSEcCtD
Amiloride—Arthralgia—Doxorubicin—prostate cancer	5.29e-05	0.000341	CcSEcCtD
Amiloride—Anorexia—Epirubicin—prostate cancer	5.22e-05	0.000337	CcSEcCtD
Amiloride—Dizziness—Capecitabine—prostate cancer	5.2e-05	0.000335	CcSEcCtD
Amiloride—Vomiting—Docetaxel—prostate cancer	5.16e-05	0.000333	CcSEcCtD
Amiloride—Rash—Docetaxel—prostate cancer	5.12e-05	0.00033	CcSEcCtD
Amiloride—Dermatitis—Docetaxel—prostate cancer	5.12e-05	0.00033	CcSEcCtD
Amiloride—Confusional state—Doxorubicin—prostate cancer	5.11e-05	0.00033	CcSEcCtD
Amiloride—Headache—Docetaxel—prostate cancer	5.09e-05	0.000328	CcSEcCtD
Amiloride—Asthenia—Prednisone—prostate cancer	5.03e-05	0.000324	CcSEcCtD
Amiloride—Vomiting—Capecitabine—prostate cancer	5e-05	0.000322	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.99e-05	0.000322	CcSEcCtD
Amiloride—Shock—Doxorubicin—prostate cancer	4.99e-05	0.000322	CcSEcCtD
Amiloride—Rash—Capecitabine—prostate cancer	4.96e-05	0.00032	CcSEcCtD
Amiloride—Pruritus—Prednisone—prostate cancer	4.96e-05	0.00032	CcSEcCtD
Amiloride—Insomnia—Epirubicin—prostate cancer	4.95e-05	0.00032	CcSEcCtD
Amiloride—Dermatitis—Capecitabine—prostate cancer	4.95e-05	0.000319	CcSEcCtD
Amiloride—Headache—Capecitabine—prostate cancer	4.93e-05	0.000318	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—prostate cancer	4.92e-05	0.000317	CcSEcCtD
Amiloride—Dyspnoea—Epirubicin—prostate cancer	4.88e-05	0.000315	CcSEcCtD
Amiloride—Somnolence—Epirubicin—prostate cancer	4.87e-05	0.000314	CcSEcCtD
Amiloride—Anorexia—Doxorubicin—prostate cancer	4.83e-05	0.000312	CcSEcCtD
Amiloride—Nausea—Docetaxel—prostate cancer	4.82e-05	0.000311	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—prostate cancer	4.82e-05	0.000311	CcSEcCtD
Amiloride—Diarrhoea—Prednisone—prostate cancer	4.79e-05	0.000309	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—prostate cancer	4.76e-05	0.000307	CcSEcCtD
Amiloride—Gastrointestinal disorder—Epirubicin—prostate cancer	4.73e-05	0.000305	CcSEcCtD
Amiloride—Fatigue—Epirubicin—prostate cancer	4.72e-05	0.000305	CcSEcCtD
Amiloride—Pain—Epirubicin—prostate cancer	4.68e-05	0.000302	CcSEcCtD
Amiloride—Constipation—Epirubicin—prostate cancer	4.68e-05	0.000302	CcSEcCtD
Amiloride—Nausea—Capecitabine—prostate cancer	4.67e-05	0.000301	CcSEcCtD
Amiloride—Dizziness—Prednisone—prostate cancer	4.63e-05	0.000299	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.62e-05	0.000298	CcSEcCtD
Amiloride—Insomnia—Doxorubicin—prostate cancer	4.58e-05	0.000296	CcSEcCtD
Amiloride—Paraesthesia—Doxorubicin—prostate cancer	4.55e-05	0.000294	CcSEcCtD
Amiloride—Dyspnoea—Doxorubicin—prostate cancer	4.52e-05	0.000291	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—prostate cancer	4.51e-05	0.000291	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—prostate cancer	4.51e-05	0.000291	CcSEcCtD
Amiloride—Gastrointestinal pain—Epirubicin—prostate cancer	4.48e-05	0.000289	CcSEcCtD
Amiloride—Dyspepsia—Doxorubicin—prostate cancer	4.46e-05	0.000288	CcSEcCtD
Amiloride—Vomiting—Prednisone—prostate cancer	4.45e-05	0.000287	CcSEcCtD
Amiloride—Rash—Prednisone—prostate cancer	4.42e-05	0.000285	CcSEcCtD
Amiloride—Dermatitis—Prednisone—prostate cancer	4.41e-05	0.000285	CcSEcCtD
Amiloride—Decreased appetite—Doxorubicin—prostate cancer	4.41e-05	0.000284	CcSEcCtD
Amiloride—Headache—Prednisone—prostate cancer	4.39e-05	0.000283	CcSEcCtD
Amiloride—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.38e-05	0.000282	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—prostate cancer	4.37e-05	0.000282	CcSEcCtD
Amiloride—Constipation—Doxorubicin—prostate cancer	4.33e-05	0.00028	CcSEcCtD
Amiloride—Pain—Doxorubicin—prostate cancer	4.33e-05	0.00028	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—prostate cancer	4.33e-05	0.000279	CcSEcCtD
Amiloride—Feeling abnormal—Doxorubicin—prostate cancer	4.18e-05	0.000269	CcSEcCtD
Amiloride—Nausea—Prednisone—prostate cancer	4.16e-05	0.000268	CcSEcCtD
Amiloride—Gastrointestinal pain—Doxorubicin—prostate cancer	4.14e-05	0.000267	CcSEcCtD
Amiloride—Abdominal pain—Doxorubicin—prostate cancer	4.01e-05	0.000258	CcSEcCtD
Amiloride—Asthenia—Epirubicin—prostate cancer	3.93e-05	0.000254	CcSEcCtD
Amiloride—Pruritus—Epirubicin—prostate cancer	3.88e-05	0.00025	CcSEcCtD
Amiloride—Diarrhoea—Epirubicin—prostate cancer	3.75e-05	0.000242	CcSEcCtD
Amiloride—Asthenia—Doxorubicin—prostate cancer	3.64e-05	0.000235	CcSEcCtD
Amiloride—Dizziness—Epirubicin—prostate cancer	3.62e-05	0.000234	CcSEcCtD
Amiloride—Pruritus—Doxorubicin—prostate cancer	3.59e-05	0.000231	CcSEcCtD
Amiloride—Vomiting—Epirubicin—prostate cancer	3.48e-05	0.000225	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—prostate cancer	3.47e-05	0.000224	CcSEcCtD
Amiloride—Rash—Epirubicin—prostate cancer	3.45e-05	0.000223	CcSEcCtD
Amiloride—Dermatitis—Epirubicin—prostate cancer	3.45e-05	0.000223	CcSEcCtD
Amiloride—Headache—Epirubicin—prostate cancer	3.43e-05	0.000221	CcSEcCtD
Amiloride—Dizziness—Doxorubicin—prostate cancer	3.35e-05	0.000216	CcSEcCtD
Amiloride—Nausea—Epirubicin—prostate cancer	3.25e-05	0.00021	CcSEcCtD
Amiloride—Vomiting—Doxorubicin—prostate cancer	3.22e-05	0.000208	CcSEcCtD
Amiloride—Rash—Doxorubicin—prostate cancer	3.2e-05	0.000206	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—prostate cancer	3.19e-05	0.000206	CcSEcCtD
Amiloride—Headache—Doxorubicin—prostate cancer	3.18e-05	0.000205	CcSEcCtD
Amiloride—Nausea—Doxorubicin—prostate cancer	3.01e-05	0.000194	CcSEcCtD
Amiloride—SLC22A2—Metabolism—AOX1—prostate cancer	1.65e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM3—prostate cancer	1.65e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAGLU—prostate cancer	1.65e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RFK—prostate cancer	1.65e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SULT2B1—prostate cancer	1.65e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PGAM2—prostate cancer	1.65e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MBTPS1—prostate cancer	1.65e-05	0.000121	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—prostate cancer	1.64e-05	0.00012	CbGpPWpGaD
Amiloride—SLC9A1—Disease—INS—prostate cancer	1.64e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CKMT2—prostate cancer	1.63e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UGT2B15—prostate cancer	1.63e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GRHPR—prostate cancer	1.63e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UGT2B17—prostate cancer	1.63e-05	0.00012	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CREBBP—prostate cancer	1.61e-05	0.000118	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAV1—prostate cancer	1.59e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GNG5—prostate cancer	1.59e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AMACR—prostate cancer	1.56e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP3A43—prostate cancer	1.56e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SRD5A2—prostate cancer	1.56e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—DEGS1—prostate cancer	1.56e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAT1—prostate cancer	1.56e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PGAM2—prostate cancer	1.54e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MBTPS1—prostate cancer	1.54e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAGLU—prostate cancer	1.54e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM3—prostate cancer	1.54e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RFK—prostate cancer	1.54e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SULT2B1—prostate cancer	1.54e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AOX1—prostate cancer	1.54e-05	0.000113	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAP2K1—prostate cancer	1.53e-05	0.000112	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CD—prostate cancer	1.52e-05	0.000112	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—prostate cancer	1.51e-05	0.00011	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—prostate cancer	1.51e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD17B1—prostate cancer	1.49e-05	0.000109	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.48e-05	0.000109	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—prostate cancer	1.46e-05	0.000107	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF2—prostate cancer	1.46e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP3A43—prostate cancer	1.46e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AMACR—prostate cancer	1.46e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—DEGS1—prostate cancer	1.46e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAT1—prostate cancer	1.46e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SRD5A2—prostate cancer	1.46e-05	0.000107	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—prostate cancer	1.45e-05	0.000106	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—prostate cancer	1.44e-05	0.000105	CbGpPWpGaD
Amiloride—SLC9A1—Disease—JAK2—prostate cancer	1.4e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD17B1—prostate cancer	1.39e-05	0.000102	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—INS—prostate cancer	1.37e-05	0.000101	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MDM2—prostate cancer	1.37e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.36e-05	9.94e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CREBBP—prostate cancer	1.35e-05	9.86e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—prostate cancer	1.35e-05	9.86e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—B4GALT4—prostate cancer	1.33e-05	9.74e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HPGD—prostate cancer	1.33e-05	9.74e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CB—prostate cancer	1.33e-05	9.73e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—prostate cancer	1.32e-05	9.64e-05	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.31e-05	9.63e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MDM2—prostate cancer	1.28e-05	9.39e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.28e-05	9.37e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CD—prostate cancer	1.28e-05	9.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.26e-05	9.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TNFRSF21—prostate cancer	1.25e-05	9.16e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—prostate cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—B4GALT4—prostate cancer	1.24e-05	9.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HPGD—prostate cancer	1.24e-05	9.08e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—prostate cancer	1.23e-05	9.03e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.22e-05	8.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP7B1—prostate cancer	1.22e-05	8.91e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTAP—prostate cancer	1.22e-05	8.91e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—prostate cancer	1.2e-05	8.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MDM2—prostate cancer	1.2e-05	8.76e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.19e-05	8.73e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SULT1E1—prostate cancer	1.18e-05	8.68e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SRD5A1—prostate cancer	1.18e-05	8.68e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CTNNB1—prostate cancer	1.18e-05	8.63e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TNFRSF21—prostate cancer	1.17e-05	8.53e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1A—prostate cancer	1.15e-05	8.43e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—prostate cancer	1.15e-05	8.41e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.14e-05	8.33e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP7B1—prostate cancer	1.13e-05	8.3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTAP—prostate cancer	1.13e-05	8.3e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACSL4—prostate cancer	1.13e-05	8.28e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD17B3—prostate cancer	1.13e-05	8.28e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CB—prostate cancer	1.11e-05	8.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SULT1E1—prostate cancer	1.1e-05	8.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SRD5A1—prostate cancer	1.1e-05	8.09e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—prostate cancer	1.1e-05	8.07e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EP300—prostate cancer	1.09e-05	8.02e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PHGDH—prostate cancer	1.08e-05	7.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UMPS—prostate cancer	1.08e-05	7.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ARG2—prostate cancer	1.08e-05	7.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.08e-05	7.9e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SRC—prostate cancer	1.06e-05	7.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LDHB—prostate cancer	1.06e-05	7.79e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACSL4—prostate cancer	1.05e-05	7.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD17B3—prostate cancer	1.05e-05	7.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP3A5—prostate cancer	1.04e-05	7.64e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—prostate cancer	1.03e-05	7.52e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RXRA—prostate cancer	1.03e-05	7.51e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ARG2—prostate cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UMPS—prostate cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PHGDH—prostate cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PDHA1—prostate cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TCN2—prostate cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA3—prostate cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UCP3—prostate cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1e-05	7.36e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LDHB—prostate cancer	9.91e-06	7.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MDM2—prostate cancer	9.83e-06	7.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP3A5—prostate cancer	9.72e-06	7.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC22A3—prostate cancer	9.61e-06	7.04e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD3B1—prostate cancer	9.61e-06	7.04e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—prostate cancer	9.61e-06	7.04e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RXRA—prostate cancer	9.56e-06	7e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—prostate cancer	9.54e-06	6.99e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—prostate cancer	9.51e-06	6.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PDHA1—prostate cancer	9.39e-06	6.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TCN2—prostate cancer	9.39e-06	6.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UCP3—prostate cancer	9.39e-06	6.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA3—prostate cancer	9.39e-06	6.88e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—prostate cancer	9.33e-06	6.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA4—prostate cancer	9.21e-06	6.75e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TBXAS1—prostate cancer	9.21e-06	6.75e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—EP300—prostate cancer	9.17e-06	6.71e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MDM2—prostate cancer	9.16e-06	6.71e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA2—prostate cancer	8.98e-06	6.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD3B1—prostate cancer	8.96e-06	6.56e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC22A3—prostate cancer	8.96e-06	6.56e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SULT1A1—prostate cancer	8.87e-06	6.5e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCG5—prostate cancer	8.87e-06	6.5e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—prostate cancer	8.81e-06	6.46e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA1—prostate cancer	8.66e-06	6.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TBXAS1—prostate cancer	8.59e-06	6.29e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA4—prostate cancer	8.59e-06	6.29e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTO1—prostate cancer	8.57e-06	6.28e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAT2—prostate cancer	8.57e-06	6.28e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD3B2—prostate cancer	8.57e-06	6.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA2—prostate cancer	8.37e-06	6.13e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SULT1A1—prostate cancer	8.27e-06	6.06e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCG5—prostate cancer	8.27e-06	6.06e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLCB2—prostate cancer	8.21e-06	6.02e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2C18—prostate cancer	8.21e-06	6.02e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LRP2—prostate cancer	8.21e-06	6.02e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—prostate cancer	8.1e-06	5.93e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA1—prostate cancer	8.08e-06	5.92e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—P4HB—prostate cancer	8.05e-06	5.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAT2—prostate cancer	7.98e-06	5.85e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTO1—prostate cancer	7.98e-06	5.85e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD3B2—prostate cancer	7.98e-06	5.85e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC22A1—prostate cancer	7.84e-06	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PPARA—prostate cancer	7.83e-06	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLCB2—prostate cancer	7.66e-06	5.61e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LRP2—prostate cancer	7.66e-06	5.61e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2C18—prostate cancer	7.66e-06	5.61e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SULT2A1—prostate cancer	7.64e-06	5.59e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MED12—prostate cancer	7.51e-06	5.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—P4HB—prostate cancer	7.51e-06	5.5e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNG5—prostate cancer	7.45e-06	5.46e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	7.3e-06	5.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA3—prostate cancer	7.18e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—prostate cancer	7.17e-06	5.25e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SULT2A1—prostate cancer	7.12e-06	5.21e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MED12—prostate cancer	7e-06	5.13e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNG5—prostate cancer	6.95e-06	5.09e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HPGDS—prostate cancer	6.85e-06	5.02e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2C19—prostate cancer	6.81e-06	4.99e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—prostate cancer	6.78e-06	4.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA3—prostate cancer	6.69e-06	4.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—prostate cancer	6.64e-06	4.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACHE—prostate cancer	6.64e-06	4.87e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—prostate cancer	6.61e-06	4.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2A6—prostate cancer	6.57e-06	4.81e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKR1C3—prostate cancer	6.39e-06	4.68e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HPGDS—prostate cancer	6.38e-06	4.68e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PRKACB—prostate cancer	6.35e-06	4.65e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2C19—prostate cancer	6.34e-06	4.65e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP17A1—prostate cancer	6.29e-06	4.61e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.22e-06	4.56e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—prostate cancer	6.19e-06	4.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACHE—prostate cancer	6.19e-06	4.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2A6—prostate cancer	6.12e-06	4.48e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA2—prostate cancer	5.99e-06	4.39e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKR1C3—prostate cancer	5.95e-06	4.36e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PRKACB—prostate cancer	5.92e-06	4.34e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP17A1—prostate cancer	5.86e-06	4.29e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.8e-06	4.25e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A5—prostate cancer	5.72e-06	4.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA2—prostate cancer	5.58e-06	4.09e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2E1—prostate cancer	5.58e-06	4.09e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—prostate cancer	5.54e-06	4.06e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NQO1—prostate cancer	5.52e-06	4.04e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TH—prostate cancer	5.44e-06	3.99e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP3A4—prostate cancer	5.38e-06	3.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A5—prostate cancer	5.33e-06	3.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1B1—prostate cancer	5.29e-06	3.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2E1—prostate cancer	5.2e-06	3.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NQO1—prostate cancer	5.15e-06	3.77e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GGT1—prostate cancer	5.13e-06	3.75e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TH—prostate cancer	5.07e-06	3.71e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA1—prostate cancer	5.05e-06	3.7e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP3A4—prostate cancer	5.02e-06	3.68e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP19A1—prostate cancer	4.98e-06	3.65e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1B1—prostate cancer	4.93e-06	3.61e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RXRA—prostate cancer	4.8e-06	3.52e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GGT1—prostate cancer	4.78e-06	3.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA1—prostate cancer	4.71e-06	3.45e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP19A1—prostate cancer	4.64e-06	3.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—COMT—prostate cancer	4.63e-06	3.39e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—prostate cancer	4.6e-06	3.37e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ITPR1—prostate cancer	4.53e-06	3.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RXRA—prostate cancer	4.48e-06	3.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COMT—prostate cancer	4.31e-06	3.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—prostate cancer	4.29e-06	3.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TYMS—prostate cancer	4.28e-06	3.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—prostate cancer	4.23e-06	3.1e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ITPR1—prostate cancer	4.22e-06	3.09e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPL—prostate cancer	4.15e-06	3.04e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A1—prostate cancer	4.01e-06	2.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TYMS—prostate cancer	3.99e-06	2.92e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ERCC2—prostate cancer	3.98e-06	2.91e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—prostate cancer	3.94e-06	2.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPL—prostate cancer	3.87e-06	2.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—prostate cancer	3.74e-06	2.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A1—prostate cancer	3.74e-06	2.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ERCC2—prostate cancer	3.71e-06	2.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARA—prostate cancer	3.67e-06	2.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—prostate cancer	3.49e-06	2.55e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAV1—prostate cancer	3.45e-06	2.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARA—prostate cancer	3.42e-06	2.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAV1—prostate cancer	3.21e-06	2.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—prostate cancer	3.14e-06	2.3e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—INS—prostate cancer	2.97e-06	2.18e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—prostate cancer	2.93e-06	2.15e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CREBBP—prostate cancer	2.91e-06	2.13e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—INS—prostate cancer	2.77e-06	2.03e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CD—prostate cancer	2.76e-06	2.02e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CREBBP—prostate cancer	2.71e-06	1.99e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—prostate cancer	2.61e-06	1.91e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CD—prostate cancer	2.57e-06	1.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—prostate cancer	2.43e-06	1.78e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CB—prostate cancer	2.41e-06	1.76e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—prostate cancer	2.39e-06	1.75e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CB—prostate cancer	2.24e-06	1.64e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—prostate cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—prostate cancer	2.08e-06	1.52e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—EP300—prostate cancer	1.98e-06	1.45e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—prostate cancer	1.94e-06	1.42e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—EP300—prostate cancer	1.85e-06	1.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—prostate cancer	1.47e-06	1.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—prostate cancer	1.37e-06	1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—prostate cancer	1.2e-06	8.78e-06	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—prostate cancer	1.12e-06	8.19e-06	CbGpPWpGaD
